A Novartis drug that stops abnormal cell growth in breast cancer now has an additional FDA approval treating a group of rare disorders characterized by overgrowth in various types of tissue. The regulatory decision makes the drug, Vijoice, the first approved therapy for these disorders termed "PROS."
We've made significant progress on interoperability from initiatives like the Trusted Exchange Framework and Common Agreement to health tech vendors and healthcare providers working to make patient data more accessible.
But is the interoperability glass half full or half empty? What progress have we made and what challenges remain?
This webinarsponsored by Surescripts will take stock of the past two years since the Covid-19 pandemic started and explore the progress we've made.
By Stephanie Baum Wednesday, April 6, 2022 5:32 PM
MedCity INVEST PharmaTech, a virtual conference scheduled for July 26, will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how to adopt digital strategies to transform every aspect of the pharma industry.
By Randall Shafer Wednesday, April 6, 2022 2:00 PM
When designed effectively, digital payment and financial communications can have a substantial impact on a hospital or health system's bottom line. But patients still commonly receive their bills by mail.
By Dr. Alan Daniels Wednesday, April 6, 2022 9:00 AM
Surgery is not always the best answer for orthopedic problems. Often behavior modifications that help with losing weight and increasing mobility, such as exercise, stretching and making dietary improvements, can successfully address musculoskeletal issues while also reducing healthcare spending.
XACT Robotics provides real-time monitoring and guided image planning with both precise robotic insertion and non-linear steering that executives believe can lead to better patient outcomes and lower hospital costs for percutaneous procedures done by interventional radiologic means.
The rising cost of employer-sponsored healthcare makes it difficult for American businesses to compete globally. That doesn't have to be the reality. Learn how one company changed its trajectory.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments